Empower Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.3M Sell
168,610
-30,301
-15% -$3.5M 0.05% 137
2025
Q4
$20.9M Buy
198,911
+31,638
+19% +$2.97M 0.06% 141
2025
Q3
$14M Buy
167,273
+376
+0.2% +$31K 0.04% 148
2025
Q2
$13.2M Buy
166,897
+11,043
+7% +$878K 0.04% 152
2025
Q1
$14M Buy
155,854
+15,342
+11% +$1.43M 0.05% 145
2024
Q4
$14M Buy
140,512
+1,287
+0.9% +$133K 0.05% 147
2024
Q3
$15.8M Sell
139,225
-192
-0.1% -$22.8K 0.05% 137
2024
Q2
$17.3M Sell
139,417
-3,052
-2% -$393K 0.06% 131
2024
Q1
$18.8M Sell
142,469
-3,911
-3% -$482K 0.07% 126
2023
Q4
$16M Sell
146,380
-5,476
-4% -$568K 0.06% 140
2023
Q3
$15.6M Buy
151,856
+1,573
+1% +$170K 0.07% 129
2023
Q2
$17.3M Sell
150,283
-4,121
-3% -$468K 0.07% 130
2023
Q1
$16.8M Buy
+154,404
New +$16.7M 0.08% 131

Other funds holding MRK

Empower Advisory Group's MRK Position: Q1 2026 in Review

Empower Advisory Group reduced its Merck (MRK) stake by 15% in Q1 2026, selling an estimated $3.5M and leaving 168,610 shares worth $20.3M. The position accounts for 0.05% of the portfolio, ranked #137.

Empower Advisory Group first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. The position peaked at $20.9M in Q4 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Empower Advisory Group held 168,610 shares of Merck worth $20.3M as of Q1 2026.
  • Empower Advisory Group sold 30,301 Merck shares in Q1 2026, an estimated $3.5M.
  • Merck made up 0.05% of Empower Advisory Group's portfolio in Q1 2026, its #137 holding.
  • Empower Advisory Group first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • Empower Advisory Group's Merck position peaked at $20.9M in Q4 2025.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Empower Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.